What are the risk factors that indicate a choroidal nevus is high risk?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

High-Risk Features of Choroidal Nevus

A choroidal nevus is considered high-risk for transformation into melanoma when it demonstrates specific clinical and imaging features, best remembered by the mnemonic TFSOM-DIM: Thickness >2mm, subretinal Fluid, Symptoms (visual acuity ≤20/50), Orange pigment, Melanoma hollow on ultrasound, and DIaMeter >5mm. 1

The Six High-Risk Factors

Based on the most comprehensive analysis of 3,806 choroidal nevi with multimodal imaging, the following features predict malignant transformation 1:

1. Thickness >2 mm (measured by ultrasonography)

  • Hazard ratio: 3.80 for transformation
  • This is the single strongest predictor of malignant transformation 1

2. Subretinal Fluid (detected on OCT)

  • Hazard ratio: 3.00 when present as a cap over the nevus
  • Hazard ratio: 3.56 when fluid is ≤3mm from nevus margin
  • OCT is essential for detecting this feature 1

3. Symptomatic vision loss (visual acuity ≤20/50)

  • Hazard ratio: 2.28
  • This factor, combined with orange pigment, consistently yields the highest risk when present with other features 2

4. Orange pigment (lipofuscin on fundus autofluorescence)

  • Hazard ratio: 3.07
  • Appears as hyperautofluorescence on FAF imaging
  • Considered clinical evidence of an aggressive tumor 3

5. Melanoma hollow (acoustic hollowness on ultrasonography)

  • Hazard ratio: 2.10
  • Represents low internal reflectivity on ultrasound 1

6. DIaMeter >5 mm (on fundus photography)

  • Hazard ratio: 1.84
  • Giant choroidal nevi (>10mm) carry particularly elevated risk 4

Risk Stratification by Number of Factors

The cumulative presence of risk factors dramatically increases transformation risk 1:

  • 0 factors: 1% risk at 5 years (HR 0.8)
  • 1 factor: 11% risk at 5 years (HR 3.09)
  • 2 factors: 22% risk at 5 years (HR 10.6)
  • 3 factors: 34% risk at 5 years (HR 15.1)
  • 4 factors: 51% risk at 5 years (HR 15.2)
  • 5 factors: 55% risk at 5 years (HR 26.4)

Highest-Risk Combinations

Certain combinations of factors yield 70-100% transformation rates 5:

  • With 4 factors: 6 of 15 possible combinations reach 70-100% transformation
  • With 5 factors: 2 of 5 possible combinations reach 70-100% transformation
  • Combinations always including symptoms AND orange pigment carry the highest hazard ratios 2

Growth Rate Thresholds Indicating High-Risk Cytogenetics

For nevi showing documented growth, specific thresholds predict high-risk tumor genetics 6:

Thickness Growth:

  • >0.5 mm/year: RR 1.93 for high-risk cytogenetics
  • >20% per year: RR 2.18 for high-risk cytogenetics

Basal Diameter Growth:

  • >0.7 mm/year: RR 2.22 for high-risk cytogenetics
  • >10% per year: RR 1.83 for high-risk cytogenetics

Clinical Examination Findings

Beyond imaging, fundoscopic examination may reveal 7:

  • Hyperpigmented or amelanotic elevated choroidal mass
  • Overlying drusen (suggests chronicity but doesn't exclude risk)
  • Retinal pigment epithelial atrophy, hyperplasia, or fibrous metaplasia
  • Clearly defined margins (typical of benign nevi, but not reassuring if other risk factors present)

Common Pitfalls to Avoid

  1. Don't be falsely reassured by drusen: While drusen suggest chronicity, they don't exclude transformation risk if other TFSOM-DIM factors are present 4

  2. Don't rely on single imaging modality: Multimodal imaging (OCT, ultrasound, FAF, fundus photography) is essential for accurate risk assessment 8, 1

  3. Don't ignore growth: Any documented growth warrants heightened surveillance, particularly if exceeding the thresholds above 6

  4. Don't underestimate size: Lesions >10mm (giant nevi) require particularly close monitoring regardless of other features 4

Monitoring Recommendations Based on Risk

Low-risk nevi (0-2 factors, posteriorly located): Can be monitored with photoscreening at 3-6 month intervals 9

Intermediate-risk nevi (3 factors): Require closer in-person surveillance with multimodal imaging 9

High-risk nevi (≥4 factors): Should be considered for treatment or very close monitoring given 51-55% transformation risk at 5 years 1, 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.